Cambrex Corp. announced that one of its customers is recalling a product for which Cambrex currently supplies the active pharmaceutical ingredient (API). The recall decision is not linked to Cambrex’s performance as the manufacturer of the API. The recall may impact Cambrex’s 2008 performance. Until the customer has resolved the issue, it is unknown what the impact will be. If necessary, the company will update its 2008 guidance when more information becomes available....